If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…Read more »
The high-powered diabetic cycling group Team Type 1 has once again pulled off a jaw-dropping feat: they’ve somehow caught the attention of 23andMe, one of just three celeb-status companies in the world offering “personal genomics services” — they scan people’s DNA for details on their ancestry and individual health risks — and convinced them to launch a probe into Type 1 and Type 2 diabetes.
This research could provide unprecedented insights into the genes that…
Dan Hurley, award-winning journalist and author of the new book Diabetes Rising is turning out to have some controversial views. He certainly thinks about Type 1 diabetes — which he’s lived with himself for 34 years — in different terms than I do; he’s very focused on causes and prevention, while I’m just trying to work out how to live with this thing. When I approached Dan to write a piece here at the ‘Mine…Read more »
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.…Read more »
Living in the United States, we are often stuck in a bubble of US-centric news. This is true for diabetes as much as any other topic. But as World Diabetes Day attests to, diabetes is hardly just an American thing. In reality, there’s much more going on in the global diabetes research arena than you might think (since our media announcements are pretty much limited to, err, Boston, Miami and the Bay Area). So today,…Read more »